Effects of lobectomy versus sub-lobar resection on the survival in adults with stage IA left upper lobe non-small cell lung cancer: a retrospective cohort study based on the SEER database

被引:1
|
作者
Wen, Huanshun [1 ]
Liang, Chaoyang [1 ]
机构
[1] China Japan Friendship Hosp, Dept Thorac Surg, 2 Yinghua East St, Beijing 100029, Peoples R China
关键词
Non-small cell lung cancer; Lobectomy; Sub-lobar resection; SEER; Propensity scores matched analysis; REDUCTION;
D O I
10.1159/000534195
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: To compare the survival after lobectomy (LR) and sub-lobar resection (SLR) of left upper lobe (LUL) among non-small cell lung cancer (NSCLC) patients with stage IA. Methods: This retrospective cohort research analyzed public data collected by the Surveillance, Epidemiology, and End Results (SEER) database. Tumor characteristics were determined based on the International Classification of Diseases for Oncology, 3rd edition (ICD-O-3). Propensity score matching (PSM) analysis was performed with a ratio of 1:1. Univariate and multivariable Cox proportional regression analyses were used to assess the effects of LR and SLR on the survival of the patients, with hazard ratios (HRs) and 95% confidence intervals (95%CIs). The effects were further evaluated by different subgroups of age, gender, tumor grades, histologic types, T stages. Results: Of the total 2,649 patients, 1,907 underwent the LR and 742 received SLR. Totally 998 patients died at the end of the follow-up. The median survival time of all patients were 66 (49, 87) months. After adjusting the age, gender, race, tumor grade, histologic type, T stage, examined lymph nodes, radiation, and chemotherapy, NSCLC patients with stage IA who received SLR had higher odds of death in comparison with these patients who received LR (HR=1.424, 95%CI: 1.227-1.652). After PSM, SLR was associated with higher odds of death in the patients (HR=1.35, 95%CI: 1.10-1.66). Similar results were discovered in different subpopulations. Discussion/Conclusion: The SLR was inferior to LR on the survival of NSCLC patients with stage IA.
引用
收藏
页码:525 / 532
页数:8
相关论文
共 50 条
  • [21] ASO Visual Abstract: Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical IA-Stage Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study
    Pan, Hanbo
    Zou, Ningyuan
    Tian, Yu
    Shen, Yaofeng
    Chen, Hang
    Zhu, Hongda
    Zhang, Jiaqi
    Jin, Weiqiu
    Gu, Zenan
    Ning, Junwei
    Jiang, Long
    Huang, Jia
    Luo, Qingquan
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (05) : 3483 - 3484
  • [22] Survival and pulmonary function in stage IA non-small cell lung cancer after sublobar resection versus lobectomy: An updated meta-analysis
    Mamede, Isadora
    Ribeiro, Leonardo
    Stecca, Carlos
    Escalante-Romero, Lorena
    Cypel, Marcelo
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 130 (03) : 523 - 532
  • [23] A RETROSPECTIVE STUDY: PROGNOSTIC FACTORS OF STAGE IB UPPER LOBE NON-SMALL CELL LUNG CANCER
    Yang Shentu
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S845 - S846
  • [24] Limited resection versus lobectomy in early-stage non-small cell lung cancer
    Toste, Paul A.
    Lee, Jay M.
    JOURNAL OF THORACIC DISEASE, 2016, 8 (11) : E1511 - E1513
  • [25] Comparison of Wedge Versus Lobar Resection for Stage 1 Non-Small Cell Lung Cancer: A SEER-Medicare Analysis Reply
    Cao, Jinlin
    Hu, Jian
    ANNALS OF THORACIC SURGERY, 2018, 106 (04): : 1261 - 1261
  • [26] Lobar or Sub-lobar Resection for Peripheral Clinical Stage IA=2 cm Non-small Cell Lung Cancer (NSCLC): Results From an International Randomized Phase III Trial (CALGB 140503 [Alliance])
    Altorki, N. K.
    Wang, X.
    Kozono, D.
    Watt, C.
    Landreneau, R.
    Wigle, D.
    Port, J.
    Jones, D. R.
    Conti, M.
    Ashrafi, A. S.
    Keenan, R.
    Bauer, T.
    Kohman, L. J.
    Stinchcombe, T. E.
    Vokes, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S1 - S2
  • [27] Longitudinal Quality of Life Following Sub-lobar Resection and Stereotactic Body Radiation Therapy for Early-stage Non-small Cell Lung Cancer
    Mudd, J.
    Wisnivesky, J. P.
    Stone, K.
    Slatore, C. G.
    Flores, R. M.
    Swanson, S.
    Blackstock, W.
    Smith, C.
    Chidel, M.
    Rosenzweig, K.
    Henschke, C.
    Kern, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [28] Therapeutic efficacy of sub-lobar resection with absorbable mesh I-125 brachytherapy for early stage non-small cell lung cancer (NSCLC)
    Bryant, Curtis M.
    Manning, Matthew
    Burney, Patrick
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S521 - S521
  • [29] Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study
    Wu, Bo
    Zhang, Xiang
    Feng, Nan
    Hu, Zhuozheng
    Wu, Jiajun
    Zhou, Weijun
    Wei, Yiping
    Zhang, Wenxiong
    Wang, Kang
    PLOS ONE, 2024, 19 (04):
  • [30] Wedge versus lobectomy: Comparing survival in stage I non-small cell lung cancer
    Rassias, DJ
    Kraev, A
    Vetto, J
    Torosoff, M
    Kadri, A
    Ravichandran, P
    Clement, C
    Ilves, R
    CHEST, 2005, 128 (04) : 338S - 339S